1D-LSD Micro Pellets – 10mcg
€ 12,50 – € 500,00Price range: € 12,50 through € 500,00
1D-LSD Micro Pellets are described as compressed research units associated with 1D-LSD, an N1-acylated structural analog of lysergic acid diethylamide.
The supplied source identifies the compound as 1-(1,2-dimethylcyclobutane-1-carbonyl)-LSD, a lysergamide containing a substituted cyclobutanecarbonyl group.
The source presents the product as a compact pellet-format preparation with a labeled analyte quantity, intended for controlled analytical and non-clinical laboratory research.
Relevant scientific contexts include chemical identity assessment, chromatographic characterization, structural comparison, and analytical method development involving related lysergamides.
The source refers to HPLC and mass-spectrometric verification, batch identification, and Certificate of Analysis documentation where applicable.
However, no actual batch-specific analytical report or supporting certificate was supplied.
The finished-unit analyte content, content uniformity, ingredient purity, excipient composition, and chemical form remain unverified.
The pellets are not established as certified reference materials or validated quantitative calibration standards.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
1D-LSD Micro Pellets 10mcg – Lysergamide Research Material
Product Overview
1D-LSD Micro Pellets are described as compressed research units associated with 1D-LSD, a synthetic N1-acylated lysergamide.
The supplied source identifies the named compound as 1-(1,2-dimethylcyclobutane-1-carbonyl)-lysergic acid diethylamide.
This designation describes a lysergamide structure bearing a substituted cyclobutanecarbonyl group.
The source presents the product as a compact pellet-format preparation intended for controlled analytical and non-clinical laboratory research.
The product is described as having a labeled analyte quantity per finished micro pellet.
However, no actual finished-unit assay or content-uniformity report accompanied the information.
The labeled quantity therefore remains a source-provided specification rather than an independently verified analytical result.
The supplied scientific context includes chemical identification, structural comparison, chromatographic characterization, and stability-focused investigation.
These contexts should be distinguished from verified findings about the actual finished pellets.
No batch-specific analytical identity certificate, impurity profile, or validated assay result was provided.
The source also refers to HPLC verification, mass-spectrometric analysis, batch identification, and Certificate of Analysis documentation.
These statements remain unverified without supporting records.
The finished preparation is not established as a certified reference material, validated quantitative calibrator, or approved pharmaceutical product.
Chemical Identity & Classification
The supplied source identifies 1D-LSD as an N1-acylated lysergamide structurally related to lysergic acid diethylamide.
Its descriptive chemical designation is 1-(1,2-dimethylcyclobutane-1-carbonyl)-LSD.
The substituted cyclobutanecarbonyl group distinguishes the named compound from LSD and other acylated lysergamides.
The supplied product information includes:
- Common designation: 1D-LSD
- Descriptive chemical name: 1-(1,2-Dimethylcyclobutane-1-carbonyl)-LSD
- Chemical classification: N1-acylated lysergamide
- Reported presentation: Compressed micro pellets
- Labeled analyte amount: Specified per finished pellet
- Intended designation: Research Use Only
The source does not provide a confirmed CAS Registry Number, molecular formula, molecular weight, or complete stereochemical designation for the actual batch.
These details should not be inferred solely from the abbreviated compound name.
The supplied information also does not establish the precise salt form, solvate composition, or additional formulation components present in the finished pellets.
Such distinctions are relevant when interpreting analytical measurements and chemical identity documentation.
1D-LSD should not be confused with 1cP-LSD, which contains a different N1-acyl substituent.
The two compounds are structurally related but chemically distinct.
Researchers may consult PubChem for public chemical-reference information, while ensuring that any selected entry corresponds to the actual chemical structure and stereochemical designation being examined.
Chemical & Physical Characteristics 1D-LSD Micro Pellets
The supplied source describes the product as compact micro pellets.
A compressed pellet is a finished preparation in which the named analyte may be combined with additional formulation components.
The characteristics of the complete preparation therefore differ from those of the isolated compound.
The source does not identify the excipient composition, pellet dimensions, total unit mass, manufacturing method, or surface characteristics.
No actual product-specific physical inspection report or finished-unit composition record was supplied.
The named compound contains a substituted cyclobutanecarbonyl group attached to the lysergamide framework.
This structural feature distinguishes 1D-LSD from LSD and from other lysergamide derivatives containing different N1-acyl groups.
However, structural classification alone does not establish the physicochemical characteristics of the actual pellet preparation.
The source does not provide experimentally verified solubility measurements, melting-point data, degradation profiles, or complete physical characterization.
It also does not establish the distribution of analyte throughout the compressed formulation.
Consequently, the properties of the isolated compound should not be assumed to describe the complete finished unit.
The source recommends cool, dry, dark storage and sealed packaging.
No validated product-specific stability study accompanied those recommendations.
Purity & Analytical Verification 1D-LSD Micro Pellets
The supplied source refers to a typical purity of at least 98% where verified.
However, no actual batch-specific Certificate of Analysis or laboratory report accompanied that statement.
The reported purity threshold therefore remains a supplier-provided claim rather than an independently verified result.
The source also refers to HPLC and mass spectrometry as analytical verification methods.
No chromatogram, mass spectrum, impurity profile, or independent laboratory certificate was supplied.
Accordingly, no specific purity result can be confirmed for the actual product batch.
For micro-pellet preparations, the chemical purity of the named ingredient and the actual analyte quantity in each finished unit are separate analytical characteristics.
An ingredient-purity result does not independently establish finished-unit content or content uniformity.
The source also does not establish whether any claimed purity measurement applies to isolated bulk material or the complete finished preparation.
The material is described in reference-oriented research terms.
However, no certified reference-material documentation, assigned measurement value, uncertainty statement, or metrological traceability record was supplied.
The finished pellets should therefore not be represented as certified quantitative reference standards.
Any definitive analytical claims require actual supporting batch records.
Quality Control & Batch Integrity
The supplied source refers to batch identification, analytical verification, and Certificate of Analysis documentation.
These statements describe proposed or claimed quality-assurance practices.
No actual certificate, independent testing report, manufacturing audit, or batch-specific quality-control record accompanied the information.
They therefore remain unverified supplier claims.
For reproducible analytical documentation, relevant records may include verified chemical identifiers, confirmed stereochemical composition where available, batch number, analytical findings, receipt date, and available storage history.
For compressed preparations, the identity and purity of the named compound should be distinguished from the composition and consistency of the finished units.
The supplied information does not establish independently verified analyte content, excipient composition, or content uniformity.
The source also does not provide evidence that every finished micro pellet meets a particular quantitative specification.
The Research Use Only designation describes intended positioning but does not independently demonstrate manufacturing quality or analytical traceability.
Claims concerning batch consistency and validated analytical performance should be supported by actual records.
Safety, Handling & Laboratory Precautions
1D-LSD is a synthetic lysergamide associated with potential pharmacological activity and significant toxicological uncertainty.
The supplied source does not provide a complete product-specific toxicological assessment.
Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.
Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.
The micro-pellet presentation does not establish safety for human or veterinary exposure.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.
Because the actual chemical form, ingredient purity, excipient composition, and finished-unit content have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.
Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.
Packaging, Labeling & Storage
The supplied source describes discreet packaging, batch-aware handling, and protective shipment arrangements.
No actual packaging specification, container-validation report, or shipment-condition record was provided.
The source recommends storage in a tightly sealed, light-protective container in a cool, dry environment.
It also refers to refrigeration as a possible storage recommendation.
No validated product-specific stability study was supplied to establish a particular storage temperature or shelf life.
Laboratory inventory records should preserve the product designation, any available batch identifier, receipt details, and relevant storage observations.
The labeled analyte quantity should be recorded as a source-provided specification unless independently verified.
Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional procedures.
Intended Research Use & Market Positioning
The supplied scientific context places 1D-LSD within analytical research involving lysergamide chemical identity, N1-acyl substitution, and comparative structural characterization.
The substituted cyclobutanecarbonyl group provides a distinguishing structural feature relevant to chemical analysis.
The source also describes interest in chromatographic profiling and stability-focused investigation.
However, no product-specific analytical validation, receptor-binding dataset, or stability study was supplied for the actual micro pellets.
For comparative catalog context, Raw Lab Chems lists 1cP-LSD Blotters, 1cP-LSD Micro Blotters, and 1cP-LSD Micro Pellets.
These three listings refer to 1cP-LSD rather than 1D-LSD.
Although the compounds belong to the same broad lysergamide family, their N1-acyl substituents differ.
They should not be treated as chemically identical or analytically interchangeable.
The supplied information does not establish equivalent chemical purity, analyte content, excipient composition, or content uniformity across these preparations.
These catalog references should not be interpreted as evidence of certified reference-material status or validated quantitative equivalence.
The actual product URL for 1D-LSD Micro Pellets was not supplied.
Ordering, Availability & Fulfillment
The supplied source describes protective packaging, international shipping, tracking, and secure handling arrangements.
It also identifies possible labeled pack sizes.
No current inventory record, confirmed pack-size listing, carrier agreement, shipment authorization, or verified delivery information was supplied.
Consequently, no availability, pack-size, delivery-time, customs-clearance, or transportation-compliance guarantee is asserted.
1D-LSD may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.
Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.
Research-only labeling does not establish a legal exemption.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
1D-LSD is a synthetic lysergamide whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.
The supplied information does not establish universal legal status or regulatory authorization.
Institutions remain responsible for determining applicable legal requirements and obtaining any necessary permissions.
No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.
| Quantity (pellets) |
5 ,10 ,25 ,50 ,100 ,250 ,500 |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.